Campbell & Co Investment Adviser’s Fresenius Medical Care FMS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,104	Closed	-$849K	–	1233
2025 Q1	$849K	Buy	34,104 +22,510	+194%	+$536K	0.07%	489
2024 Q4	$262K	Sell	11,594 -19,419	-63%	-$422K	0.02%	886
2024 Q3	$661K	Buy	31,013 +16,987	+121%	+$334K	0.05%	599
2024 Q2	$268K	Buy	14,026 +1,971	+16%	+$40.2K	0.02%	868
2024 Q1	$232K	Buy	+12,055	New	+$239K	0.02%	983
2022 Q4	–	Sell	-92,280	Closed	-$1.3M	–	847
2022 Q3	$1.3M	Buy	+92,280	New	+$1.74M	0.29%	69
2020 Q1	–	Sell	-21,170	Closed	-$780K	–	204
2019 Q4	$780K	Buy	+21,170	New	+$751K	0.24%	98

Other funds holding FMS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Campbell & Co Investment Adviser's FMS Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of Fresenius Medical Care (FMS) in Q2 2025, closing a stake of 34,104 shares — an estimated $849K sold.

Campbell & Co Investment Adviser first reported a position in FMS in Q4 2019 and held it in 7 quarters. The position peaked at $1.3M in Q3 2022. 207 funds tracked by Wall St. Rank hold FMS as of Q2 2025.

Campbell & Co Investment Adviser reported no remaining Fresenius Medical Care position as of Q2 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 34,104 Fresenius Medical Care shares in Q2 2025, an estimated $849K.
Campbell & Co Investment Adviser first reported a position in Fresenius Medical Care in Q4 2019 and held it in 7 quarters.
Campbell & Co Investment Adviser's Fresenius Medical Care position peaked at $1.3M in Q3 2022.
207 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.